Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 2009

View Archived Issues

FDA grants priority review to Shire's NDA for velaglucerase alfa in Gaucher disease

Oroxcell discovers novel sodium channel inhibitors for the treatment of pain

Graceway acquires worldwide rights to GS-9191 from Gilead Sciences

Phase III results show activity of omiganan 1% gel against catheter-related infections

FDA grants clearance to Arkray's Glucocard Vital blood glucose monitoring system

Bupropion improves hypoactive sexual desire disorder in women

Guided Therapeutics reports trial results of LightTouch in cervical cancer detection

Interim results of phase III study with CIMAvax EGF vaccine in NSCLC reported

Tesofensine effects on weight lead to phase III investigation

Subcutaneous abatacept may be delivered without methotrexate to treat RA

Pilot clinical data suggest beneficial effects of transdermal nicotine in mild cognitive impairment

Azathioprine superior to mycophenolate mofetil as maintenance therapy for ANCA-AAV

Gruenenthal presents ORL1 and mu-opioid receptor ligands as analgesics

IRM claims GDIR ligands for the treatment of diabetes and obesity

China Medical Technologies receives approval for its leukemia gene detection probe

Compugen discovers genetic biomarker for predisposition to type 2 diabetes

Evotec and Boehringer Ingelheim extend research collaboration

Bristol-Myers Squibb discloses IGF-1R inhibitors for the treatment of cancer

Daval's Aimspro is designated orphan drug for amyotrophic lateral sclerosis

Xoma to develop XOMA-052 antibody for cardiovascular diseases

Genmab starts phase III trial of ofatumumab in diffuse large B-cell lymphoma

Health Canada accepts for review EpiCept's NDS for Ceplene in AML

FDA extends review date of GSK's and XenoPort's NDA for gabapentin enacarbil

Concert Pharmaceuticals begins phase Ib clinical trial of HIV therapeutic CTP-518

D-Pharm enters into collaboration with Wanbang Biopharmaceuticals for DP-b99

GlaxoSmithKline reports third quarter 2009 results

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...